source
- Merck's Lipfendra pill receives FDA approval as first oral PCSK9 cholesterol treatmentThe U.S. Food and Drug Administration approved Lipfendra, an oral medication from Merck that lowers low density lipoprotein cholesterol. The drug blocks the PCSK9 protein, making it the first pill…
- FDA approves Merck’s first oral PCSK9 inhibitor, marking a first for the drug classThe U.S. Food and Drug Administration has granted approval to Merck for its oral PCSK9 inhibitor, the first drug of this type to receive such clearance. The approval represents a milestone because…